Campaign to save five-year-old cancer sufferer has become one of the fastest online charity appeals EVER – The Sun

A CAMPAIGN to save a five year old cancer sufferer has become one of the fastest online charity appeals after reaching its 500,000 target in just three weeks.

The parents of Oscar Saxelby-Lee are gobsmacked to have reached the huge amount to fund the emergency life saving treatment abroad in under a month.

1

Thousands have pledged the cash meaning he will now fly to Singapore to undergo potentially life-saving CAR-T cell therapy and a second bone marrow transplant in a bid to save his life.

Oscars battle has always drawn huge support and in March almost 5,000 people queued in the rain to find a stem cell donor to cure Oscar, from Worcester.

But despite finding a match, doctors discovered the rare T-cell acute lymphoblastic leukaemia had returned so Oscars parents launched the new appeal in September.

Olivia, 26, and Jamie, 23, have now thanked kindhearted givers who organised events from sponsored bike rides to non-uniform days to raise the incredible sum.

In a statement, the pair said: We are absolutely gobsmacked with the amount of humbling support we have received since the word go.

Over the last three weeks, we have watched the people of Worcestershire and beyond work together to raise this seemingly impossible amount of money.

It has been heart-warming to see schools, businesses, individuals and even children giving all they can.

We would like to thank you from the bottom of our hearts - you are truly amazing.

Doctors at Birmingham Childrens Hospital, where Oscar has been treated since last December, say he has only a short window in which he will be strong enough to travel.

But Oscars parents have urged people to carry on supporting them, saying they need help more than ever.

They added: Now we need to make sure that we have contingency funds available should Oscar need more care or have a more complicated recovery whilst there.

As we all know, this journey hasnt gone smoothly so we must be prepared for any additional hurdles.

As you will have seen from Oscars Facebook page, Oscar has needed to receive more treatment and have further tests done whilst we have been fundraising to keep his leukaemia at bay.

Now we have the difficult bit, the waiting.

Warning

HANGING BY A THREAD Teen had to catch her jaw after it was torn off in horse riding smash

Raising awareness All you need to know about World Mental Health Day and how to take part

hard to swallow Ban all food from trains & buses to tackle obesity, urges top doc

URGENT RECALL Common heartburn drugs recalled over cancer-causing toxin contamination fears

ROYAL MINDNESSES Fab Four reunite for 1st ever TV advert tonight in mental health campaign

VAPE CRISIS US vaping deaths hit 21 & disease cases surge to 1,000 as people urged to stop

The initial funds are ready. Oscars medical team now need to wait for the results of his further tests, which determine the next steps.

When the best treatment plan for Oscar is confirmed by his medical team, having this funding will allow us to move very quickly.

Thank you so much to the people of Worcestershire and beyond for making this possible and once again doing everything in their power to help save our boy.

Read the original post:
Campaign to save five-year-old cancer sufferer has become one of the fastest online charity appeals EVER - The Sun

Six people with links to UCLH listed among most influential people in London – University College London Hospitals

The Progress 1000 is compiled every year. The theme of this years list is the future and technology, and embraces whole new sectors including augmented and virtual reality and cyber security, as well as a wide range of activists challenging inequality and helping the environment.

Dr Prasanna Sooriakumaran, a consultant prostate cancer surgeon at UCLH, was included for his pioneering robotic surgery. He is investigating new techniques to spare men with prostate cancer the potentially debilitating effects of surgery. Early trials show that his new technique has drastically reduced recovery time for up to 94 per cent of patients.

Prasanna said: It is a great honour to top the list of Londons most influential doctors in the Progress 1000 after having also made the list last year. This is a testament to the wonderful staff at UCLH, who provide world class care to men with prostate cancer.

Professor Bryan Williams is director of one of the UKs leading NIHR Biomedical Research Centres at UCLH, director of research at UCLH and Chair of Medicine at UCL. He is a clinician at UCLH and is recognised as one of the worlds leading authorities on high blood pressure.

He said: It is good to see recognition of the influence that staff at UCLH have in driving forward medical research and innovation in London and beyond.

Professor Charles Swanton, UCLs professor of personalised cancer medicine with a lab at UCL Cancer Institute and the Francis Crick Institute in Kings Cross, a consultant at UCLH and chief clinician at Cancer Research UK, is leading pioneering research on lung cancer. Professor Swanton studies how cancers evolve in the body to spread and become resistant to therapy. He is also researching ways to treat tumours more effectively.

Charlie said: This is a great testament to the hospital, university, Crick and CRUK and the team for making TRACERx possible.

Professor Tariq Enver, director at UCL Cancer Institute and professor of stem cell biology at UCL, leads a grand coalition in the war on cancer by encouraging closer working relations between UCL, Kings College London, Queen Mary University of London and the Francis Crick Institute, creating a centre of excellence for biotherapeutics.

Tariq said: It is fantastic that the vital work being done by the team in London - which has the potential to transform cancer treatment in the long run is being recognised and encouraged. Being nominated is a massive boost for all of us who have worked so hard to reach this point.

Professor Ravi Gupta, until recently an infectious diseases clinician at UCLHs Hospital for Tropical Diseases, studies the evolution and spread of HIV drug resistance globally. He, along with colleagues at Imperial College London, recently published a report on how a patient with HIV and lymphoma is now free from both conditions after an allogeneic stem cell transplant using cells from a donor lacking a critical receptor protein for HIV infection, CCR5. This work has rejuvenated the field of HIV gene therapy.

He said: It has been humbling to work at UCLH alongside such dedicated staff, both clinical and academic. I hope that recognition of the London Patient HIV cure in the Progress 1000 list will serve as an inspiration in London and beyond in the fight against HIV/AIDS.

Professor Chris Whitty, the chief medical officer for England and a UCLH physician, was included on the list for his work which focuses on the diagnosis and management of infectious diseases in children and adults.

Read this article:
Six people with links to UCLH listed among most influential people in London - University College London Hospitals

Injection therapy has many faces | News, Sports, Jobs – Marquette Mining Journal

You wake up one morning to find that slight twinge in your hip has become significantly painful. Youve tried icing and ibuprofen but the pain is now severe and demands medical attention. What are you expecting the doctor to do?

As a weekend warrior, you expect some aches and pains following your regular game but that twisted ankle you experienced last weekend continues to hurt with every step. Once again, the typical home treatments, the familiar rest-ice-compression-elevation, have helped, but not enough. Greater expertise is needed.

The arthritic knee, damaged playing college sports, has been bearable for years, but that joint has become progressively more symptomatic over recent months. What are the options? Some pain relief is desired.

These are all common scenarios. A frequent answer to these question is an injection. Many physicians first recommendation for various problems will be an injection. But what exactly is being administered? Most people are aware of a few of the options, yet a plethora of substances can be administered via injection. Injection therapy is a technique practiced for many years and continues to be utilized as a safe, easily performed procedure in an office or out-patient setting.

Specifically, an injection is the act of putting a liquid, especially a drug, into a persons body using a needle and syringe. This is a technique for delivering drugs without significant quantities of the drug spreading throughout the body. Intra-articular injections, those performed into a joint, have a number of physiologic and practical advantages over systemic medications (such as those taken by mouth), including safety.

Many fear injections. Certainly, the pain produced can occasionally be considerable but, more often, is minimal to mild. Others have allowed hearsay and rumor to rule their decision making, claiming they shouldnt have any injections because theyre going to do more harm than good. It is true sometimes the relief is temporary, but if you dont want to have surgery, an injection is an approach for musculoskeletal conditions that should be attempted. It may only give you a few months of pain relief, but it is usually worth trying.

As anyone who has had more than one injection can attest, the symptoms produced by the procedure itself can vary greatly. When larger structures are injected, the procedure tends to be more painful. Yet, there are a variety of methods to reduce the discomfort. As you would expect, technique is a critical factor. Pushing the liquid in faster, although shortening the duration of the process, is more uncomfortable. Thus, patience on the part of the health care provider is beneficial.

Buffering the solution is helpful when the solution is acidic, as is often the case when local anesthetics are used. Understandably, a smaller needle will produce less discomfort, although some medications will not get through certain sized needles. Additionally, the use of an ethyl chloride or cold spray numbs the skin for an instant but greatly reduces the initial pain of penetration.

Injection therapy can be used to achieve many different goals, other than just pain relief. The administration of a local anesthetic, a medication which temporarily produces a sensory blockade, can be used for diagnostic purposes. If some particular body part is injected with an anesthetic, and the pain previously experienced is gone while the numbing agent is active, then we can surmise that structure is causing the pain.

Clearly, the benefits of an injection will depend largely on what is injected. Without question, the most commonly utilized medication is some type of corticosteroid, commonly referred to as cortisone, although that particular medicine is no longer in common use. Corticosteroids are not harmful when used appropriately, and have many different uses. Corticosteroid injections can be therapeutic and diagnostic. They reduce inflammation by inhibiting the production of a number of inflammatory substances. But because they can cause some thinning of tissue, they can be put into a cyst or scar tissue to reduce its mass.

Injections directly into an arthritic joint avoid conventional barriers to joint entry. Intra-articular injections are a minimally invasive procedure and can be performed easily in an outpatient setting, with a short recovery time. Again, there is a drastically lower risk of side effects or systemic toxicity due to this delivery method. Intra-articular corticosteroids are approved by the FDA, although concerns remain regarding the duration of its effects, and their safety profile. And if the situation leading to inflammation is not addressed, predictably, the relief of the steroid injection will be transient.

All medicines have some side effects, including steroids. When used unwisely, what was once a benefit can be a complication. Common side effects are a loss of skin fat, discoloration of the skin, and increased blood sugars. This latter effect is of particular concern in the diabetic population. Uncommon side effects, more likely when used inappropriately, are tendon ruptures or ligament tears.

Patients may be disappointed when they are told the injection recommended may be helpful for only a short time. For each pathology injected, the duration of relief can vary greatly. There are no guarantees with any medical procedure, and this includes injection therapies. The possibility it can provide relief and make some condition better seems a realistic goal, as opposed to trying to give a patient a specific timeline.

Over the last few decades there has been tremendous research into new therapies, with great interest in regenerative medicine. The basic concept is to find healthy ways to improve the bodys healing processes. Some of these newer techniques involve an injection. Some examples include PRP injections (platelet-rich plasma), stem cell therapies, and amniotic membrane injection. Benefits of regenerative medicine techniques include an improved safety profile and, maybe most important, the direct targeting of the biochemistry of osteoarthritis. An increase in movement may be seen, as well as improved muscle strength. They seem to be useful in treating repetitive stress injuries that havent healed properly or completely. Maybe most consequential is the reduction of pain levels. The hope is these novel methods may allow some to avoid surgery and can even lead to healing.

One concern with these new technologies is the lack of large scale clinical trials to back up these claims. Long-term clinical studies are needed to increase the evidence available about them, and so earn consideration in treatment frameworks. Until these are performed, there remains an element of uncertainty with these methods.

The regenerative medicine technique in longest use is prolotherapy, in which a highly concentrated glucose solution is injected into a tendon or ligament. This seems to jump-start the healing process, with the resulting inflammation being a natural and integral component of healing, as with platelet rich plasma injection. When performed into a damaged part, these injections can stimulate repair.

Botox injections are a completely different type of injectable therapy. This substance blocks certain chemical signals from nerves, especially those causing muscles to contract. Some common uses are to relax facial muscles (those causing wrinkles) or muscle spasms. Botox injections may also help prevent chronic migraines.

Getting a therapeutic injection can be a scary process and, occasionally, a painful one. Still, there are ways to reduce this. As with any treatment, these methods can be misused. And, once again, there are no guarantees in health care. But the benefits can be significant. Dont make assumptions: steroids can lead to healing, depending on the situation, and can significantly reduce pain. Dont let fear rule your decision-making process. Consider carefully all the options your health care team recommends. An injection may be your most effective path to relief.

Editors note: Dr. Conway McLean is a physician practicing foot and ankle medicine in the Upper Peninsula, with a move of his Marquette office to the downtown area. McLean has lectured internationally on wound care and surgery, being double board certified in surgery, and also in wound care. He has a sub-specialty in foot-ankle orthotics. Dr. McLean welcomes questions or comments atdrcmclean@outlook.com.

View original post here:
Injection therapy has many faces | News, Sports, Jobs - Marquette Mining Journal

Michelle Wie exclusive interview: How golf’s great prodigy grew up – The Telegraph

But a long list of injuries: to neck, back, knee, hip and ankle, has curtailed that prodigious talent, so much so that she is able to bond with Tiger Woods over the travails of the treatment table.

Ive seen Tiger a couple of times [since her time out], Wie says. Its pretty funny that every time we lift off with, Hows your neck, hows your back? and hes like, Hows your this, hows your that? It takes about 10 minutes of checking off the injuries before we talk normally.

Its comforting talking to other athletes going through the same things. Sport can be harsh, but other stories can hit home and normalise it. It can give you a boost of energy to go again.

That does involve waiting until her wrist has healed. It is an injury which was plagued her since she fractured her right hand in a car accident two years ago. Wie is arthritic in both wrists and has just finished the latest round of platelet-rich plasma (PRP) injections to accelerate the healing of her injured ligaments. Her daily routine has become one of treatment, icing, recovery, therapy and repeat.

The break has provided a time for reflection, especially as she nears a milestone birthday. The twenties are hard, Wie says. They are too hyped. I think the twenties are the years you figure things out and Im excited about being in my thirties. Theres still so much more I want to accomplish.

With a degree in communications obtained from Stanford University, a career in TV when she hangs up the clubs looks the most likely option. Her commentary debut for the Golf Channel at the Solheim Cup was unsurprisingly assured.

See the original post here:
Michelle Wie exclusive interview: How golf's great prodigy grew up - The Telegraph

Cell Expansion Market is expected to rise at a remarkable CAGR during the Forecast Period 2016 2024 – Space Market Research

Global Cell Expansion Market: Overview

This report on the global cell expansion market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases.

The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global Cell Expansion market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

Get Sample Copy of This Report At: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9037&source=atm

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global cell expansion market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increase in prevalence of cancer and rare diseases, rise in demand for regenerative and cell-based therapies and historical year-on-year growth have been taken into consideration while estimating the market size.

Global Cell Expansion Market: Segmentation

The cell expansion market has segmented into four categories, namely by type of cells, by product, by end-user and by region.

Geographically, the global Cell Expansion market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Saudi Arabia, UAE, Brazil, and Mexico.

Request for Ask An Analyst About This Report At: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=9037&source=atm

Global Cell Expansion Market: Competitive Landscape

The report also profiles major players in the cell expansion market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include GE Healthcare, Danaher Corporation (Pall Corporation), Terumo Corporation, Merck Millipore (Merck KGaA), Octane Biotech, Inc., Thermo Fisher Scientific, Inc., Lonza Group, STEMCELL Technologies, Inc., Becton, Dickinson and Company, Bio-Techne (R&D Systems), Takara Bio, Inc., Cell Signaling Technology, Inc., PeproTech, CellGenix GmbH, Corning Incorporated, Eppendorf AG, and HiMedia Laboratories.

The global cell expansion market is segmented as follows:

Global Cell Expansion Market Revenue, by Type of Cells Human Cells Stem Cells Adult Stem Cells Induced Pluripotent Stem Cells Embryonic Stem Cells Differentiated Cells Animal Cells

Global Cell Expansion Market Revenue, by Product Type Instruments Cell Expansion Supporting Equipment Bioreactors Automated Cell Expansion Consumables Reagents Media Sera Disposables Bioreactor Accessories Tissue Culture Flasks Others

Global Cell Expansion Market Revenue, by End User Hospitals CMO & CRO Biotechnology & Pharmaceutical Companies Academic & Research Institutes

Global Cell Expansion Market Revenue, by Geography North America US Canada Europe UK Germany France Italy Spain Russia Rest of Europe Asia Pacific China Japan Australia & New Zealand Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East and Africa South Africa GCC Countries Rest of Middle East & Africa

Request For Discount On This Report At https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=9037&source=atm

Read more here:
Cell Expansion Market is expected to rise at a remarkable CAGR during the Forecast Period 2016 2024 - Space Market Research

Yale researchers develop way to help brain organoids thrive – Yale News

Brain organoids created from human embryonic stem cells offer scientists a powerful way to study the developing brain in three dimensions. However, organoids need nutrients and oxygen carried in blood to thrive, just as a developing fetal brain does. Now Yale researchers have developed a method to induce growth of blood vessels in organoids and prevent the death of cells, which has hindered efforts of scientists studying brain development, they report Oct. 7 in the journal Nature Methods.

The introduction of vasculature will hopefully lead to our ability to create larger, healthier organoids, said In-Hyun Park, associate professor of genetics and associate professor in the Child Study Center and Yale Stem Cell Center.

The development of organoids, created by spurring development of human embryonic stem cells, has been a boon to neuroscientists studying the origins of neurodevelopmental diseases such as autism and schizophrenia, which can arise from abnormalities that form early in brain development. Although just a few millimeters in diameter, organoids offer a new window into how developing regions interact in real time.

However, organoids are also prone to widespread death of cells caused by a lack of blood vessels, particularly within the interior of the developing organ. Parks lab overcame that problem by inducing the expression of hETV2, a gene associated with the creation of vasculature in the developing embryo, within human embryonic stem cells. Its studies, led by Bilal Cakir and Yangfei Xiang, found that cell death in the organoids with engineered cells dramatically decreased, but that new blood vessels were created when the organoids were transplanted into a mouse.

The rest is here:
Yale researchers develop way to help brain organoids thrive - Yale News

Catholics more motivated to donate if ethical investing is assured – The Catholic Spirit

An usher hands the collection basket to a Massgoer Oct. 28, 2018, at Jesus the Divine Word Church in Huntingtown, Md. Nearly nine in 10 Catholics surveyed said they want their donations to church institutions to be ethically invested and a majority of those responding voiced particular opposition to investments in companies that produce pornography, tobacco products and e-cigarettes, according to a new survey. CNS photo/Bob Roller

The survey for Boston-based Catholic Investment Services found that about 87% of respondents would be more likely to donate to Catholic institutions if they knew the money would be invested in ways consistent with Church teaching and values.

In contrast, about 14% of respondents said ethical investing was not a consideration when donating to Catholic institutions.

The results parallel those of a CIS survey released in April. Peter Jeton, the firms outgoing CEO, said the new study sought to more specifically identify what investments motivates or deters Catholics to give to Church entities.

People want their donations to go where its good and avoid evil, Jeton said.

Ethical investing can be a motivating factor in how much people give, he told Catholic News Service. And if I am the CFO (chief financial officer) of a diocese or if Im the bishop of a diocese, then I should be explaining very clearly and with frequency what the policy is regarding how peoples money is being invested.

The survey involved 500 Catholic adults who answered a series of online questions Sept. 7-9. It has a margin of error of plus or minus 4.5 percentage points.

It covered more than a dozen types of businesses from manufacturers of medications used during an abortion procedure to oil and natural gas mining to which respondents voiced objections.

In the case of the pornography industry, 60% of respondents said Church money should not be invested in such endeavors. Opposition also was raised to investing in tobacco products and e-cigarettes (57%), alcoholic beverages (52%), medications used during an abortion (52%), casinos and gaming (51%), medical facilities where abortions occur (50%), gun manufacturing (47%), for-profit prisons/detention centers (45%), security, defense and large-scale weapons (44%), research on embryonic stem cells (37%), manufacturers of birth control (31%) and oil and natural gas extraction (30%).

Jeton suggested that institutional financial officers and bishops be fully transparent about their investment decisions. The better the engagement, the better for the Church, he said.

They should emphasize the link with Catholic social teaching, he added. Because if our data is correct, then making people in the pews aware of that should, by all rights, increase the comfort level with the Church and a greater willingness to share more of their financial resources with the Church.

The survey also asked participants what investments Catholic institutions should be making. Among those cited by respondents were clean air and water (67%), workforce education/job training (66%), education technology (65%), agriculture and food (65%), health care providers (62%), affordable housing (60%), recycling (57%), renewable energy (53%), land conservation (50%), fitness/nutrition (49%) and banking and financial services to low-income people and small businesses (46%).

Catholic Investment Services was founded in 2013 to serve Catholic entities, including dioceses, colleges and universities, hospital systems and social service agencies. Jeton said the firm follows the socially responsible investment guidelines adopted by the U.S. Conference of Catholic Bishops.

Those guidelines, in place since 2003, are divided into six broad categories: protecting human life, promoting human dignity, reducing arms production, pursuing economic justice, protecting the environment and encouraging corporate responsibility. Each category lists specific areas of concern, such as abortion, racial discrimination, labor standards and other social needs in which the Church has had a voice.

Jeton said he hoped the data developed would influence how diocesan bishops in particular discuss finances with the folks in the pew.

They would do well to pay attention to mechanisms that would get more people engaged, Jeton said. Hopefully with greater engagement there is growing willingness (among donors) to go into their back pocket to help the Church.

Tags: Catholic Investment Services, Ethical investing

Category: U.S. & World News

Link:
Catholics more motivated to donate if ethical investing is assured - The Catholic Spirit

Stem Cell Market: By Key Players, Market Competitive Landscape, Trends and Forecasts to 2024 – Joliet Observer

Global Stem Cell Market 2019 Analysis to serve a detailed research of primary, of this world, in-between and long-term trends to support the growth of already established challengers, emerging new companies and the detailed growth rate. This report also withgrowth trends,numerousstakeholders like investors, CEOs, traders, suppliers,analysis& media,internationalManager, Director, President, SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organizationand others.

Top most List manufacturers/ Key player/ Economy by Business Leaders Leading Players of Stem Cell Market Are: CCBC, Vcanbio, Boyalife, Beikebiotech, . And More

Get a Sample PDF of Report @http://www.360marketupdates.com/enquiry/request-sample/11010241

Overview of the Stem Cell Market:

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).,

Stem Cell Market Segment by Type covers:

Stem Cell Market Segment by Applications can be divided into:

Fill the Pre-Order Enquiry form for the report @ https://www.360marketupdates.com/enquiry/pre-order-enquiry/11010241

Stem Cell Market Segment by Regions, regional analysis covers

Scope of theStem Cell MarketReport:

Look into Table of Content of Stem Cell Market Report @ https://www.360marketupdates.com/TOC/11010241#TOC

Report Answers Following Questions:

Stem Cell Market Historic Data (2013-2019):

Stem Cell Market Influencing Factors:

Stem Cell Market Forecast (2019-2024):

PurchaseStem CellMarketReport$ 4880 (Single User License)

@https://www.360marketupdates.com/purchase/11010241

CONTACT US

Mr. Ajay More

Phone:+14242530807 / + 44 20 3239 8187

Email:[emailprotected]

Read the rest here:
Stem Cell Market: By Key Players, Market Competitive Landscape, Trends and Forecasts to 2024 - Joliet Observer

Stem Cell Therapy Market to Witness a Pronounce Growth During 2020 – Gem Newz

Stem cells are most vital cells found in both humans and non-human animals. Stem cells are also known as centerpiece of regenerative medicine. Regenerative medicines have capability to grow new cells and replace damaged and dead cells. Stem cell is the precursors of all cells in the human body. It has the ability to replicate itself and repair and replace other damaged tissues in the human body. In addition, stem cell based therapies are used in the treatment of several chronic diseases such as cancer and blood disorders.

Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/3251

The global stem cell therapy market is categorized based on various modes of treatment and by therapeutic applications. The treatment segment is further sub-segmented into autologous stem cell therapy and allogeneic stem cell therapy. The application segment includes metabolic diseases, eye diseases, immune system diseases, musculoskeletal disorders, central nervous system disorders, cardiovascular diseases and wounds and injuries.

In terms of geographic, North America dominates the global stem cell therapy market due to increased research activities on stem cells. The U.S. represents the largest market for stem cell therapy followed by Canada in North America. However, Asia is expected to show high growth rates in the next five years in global stem cell therapy market due to increasing population. In addition, increasing government support by providing funds is also supporting in growth of the stem cell therapy market in Asia. China and India are expected to be the fastest growing stem cell therapy markets in Asia.

In recent time, increasing prevalence of chronic diseases and increasing funds from government organizations are some of the major drivers for global stem cell therapy market. In addition, rising awareness about stem cell therapies and increasing focus on stem cell research are also supporting in growth of global stem cell therapy market. However, less developed research infrastructure for stem cell therapies and ethical issues related to embryonic stem cells are some of the major restraints for global stem cell therapy market. In addition, complexity related with the preservation of stem cell also obstructs the growth of global stem cell therapy market.

Request Customization of this Report @https://www.persistencemarketresearch.com/request-customization/3251

Some of the major companies operating in the global stem cell therapy market are Mesoblast Ltd., Celgene Corporation, Aastrom Biosciences, Inc. and StemCells, Inc.

See more here:
Stem Cell Therapy Market to Witness a Pronounce Growth During 2020 - Gem Newz

Senior, caregivers conference and expo coming Oct. 11 – The Daily Courier

Seniors and caregivers are invited to the Senior & Caregivers Conference & Expo from 10 a.m. to 3 p.m. Friday, Oct. 11. at Liberty Traditional School, 3300 N. Lake Valley Road, Prescott Valley. This free event is sponsored by the Senior Connection, whose goal is to connect seniors and family caregivers with providers of products, services and support they may need.

The purpose of the Conference & Expo is to provide one central location where the public can learn about issues facing them in their role as a senior or caregiver, and speak with representatives from local companies that may be of help.

Presentations by local experts will occur on the hour, starting at 10 a.m., on some of the most important issues related to the challenges of being a senior or caregiver. The schedule is as follows: 10 a.m. Surviving Todays Healthcare System How to Become Your Own Advocate with Bonnie Shimko Arizona Care Management Solutions; 11 a.m. Loneliness The Silent Epidemic with Sam Downing, MD; noon Stem Cell Therapy New Hope or Snake Oil? with Wayne Bennett, DC Bennett Clinic; 1 p.m. Legal Issues for Caregivers with Chip McLaughlin Law Offices of Chester McLaughlin, P.C.; 2 p.m. Finding Hope Through Hospice with Kelly Paradis, Good Samaritan Society Hospice.

In addition to the presentations, attendees will have the opportunity to speak with representatives from approximately 60 local senior resource providers who will have information booths with literature about their products and services. Exhibitors represent a wide range of local resources, including in-home care assistance, independent and assisted living options, hospice care, legal and financial help, and health and fitness.

Debbie Stewart, CEO of Senior Connection says, There are a lot of resources available locally. However, it can be difficult to know where to begin and how to find them. Oftentimes, we dont even know what questions to ask. Dont wait until youre in the midst of a crisis to find out what help is available. Our message to Seniors and Family Caregivers is You are not alone help is available!

Attendees may stay for all or part of the day, as their schedule allows. RSVPs are not necessary.

For more information about the Senior Connection, including the online resource directory and Caregiver Connection newsletter, visit http://www.SeniorConnection.us or call 928-778-3747.

See the article here:
Senior, caregivers conference and expo coming Oct. 11 - The Daily Courier